Role of Shalishastic Pind Swedan and Sarpagandhaghan Vati in Hypertension-a pilot study

Authors

  • Savesh Kumar Singh
  • Kshipra Rajoria

Abstract

Hypertension has become a public health problem worldwide. This is the most prevalent cause for cerebrovascular and cardiovascular disorders, causing high rate of mortality and morbidity. In this disease,Vata is playing a prime role. Other Doshas are also accompanied with this Dosha. For Vata Vyadhi,Mridu Snehan, Mridu Swedan and Mridu Virechan is the treatment as indicated in ancient classical text of Ayurveda. These can be done simultaneously with Shalishastic Pinda Swedan. Sarpagandhaghan Vati is commonly used in Ayurveda for the treatment of hypertension. In this study, the selected patients of hypertension were randomly placed in three groups of 15 patients in each group. In group A, Shalishastic Pinda Swedan was administered for 30 days. In group B,Sarpagandhaghan Vati (500 mg) was orally administered both time in a day for 30days and in group C combined regime of Shalishastic Pinda Swedan and Sarpagandhaghan Vati were administered for 30days. In all the groups, significant results were found. It was found that treatment with Shalishastic Pinda Swedan was more effective than oral Sarpagandhaghan Vati treatment. Combined treatment with Shalishastic Pinda Swedan and Sarpagandhaghan Vati was most effective in all the signs and symptoms. This was due to their synergistic effect. These therapies can be used in every patients of hypertension without any side effect.

Keywords: Hypertension, Dosha, SarpagandhaghaghanVati, Shalishastic Pind Swedan.

 

Author Biography

  • Savesh Kumar Singh
    Lecturer PG department of panchakarma National institute of Ayurveda Jaipur

Downloads

Published

2015-01-14

Issue

Vol. 3 No. 3 (2014)

Section

Research/Review Articles

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is notpublished already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  • I/We also agree to the authorship of the article in the following order:

Author’s name

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.